medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2024, Número 4

<< Anterior Siguiente >>

Acta Pediatr Mex 2024; 45 (4)


Electroestimulación transcutánea en la región sacra en pacientes con vejiga urinaria hiperactiva

Cuevas AJO, Diaz GL, Aguilar ARJ, Ramos ZJA, Sánchez SF

Idioma: Español
Referencias bibliográficas: 44
Paginas: 278-285
Archivo PDF: 236.25 Kb.


RESUMEN

Objetivo: Conocer la evolución clínica con la terapia de electroestimulación transcutánea sacra (siglas en inglés: TENS) en pacientes con VH.
Materiales y Métodos: Estudio de cohorte retrospectivo de pacientes con diagnóstico de VH que recibieron tratamiento con TENS transcutánea en la región sacra.
Resultados: Se incluyeron 19 pacientes con VH, 12 femeninos y 7 masculinos, con seguimiento de 12 a 32 meses. 13 de los 19 casos, recibieron tratamiento previo con anticolinérgicos y/o toxina botulínica tipo A. La polaquiuria y la incontinencia de urgencia diurna mejoraron en 100% y 87.5% respectivamente. El estreñimiento crónico se corrigió completamente en todos los casos con laxante y TENS. En la enuresis asociada a VH la respuesta al TENS fue baja.
Conclusiones: Los síntomas de VH muestran buena respuesta a la TENS en región sacra, sin efectos colaterales indeseables. La combinación de un laxante con TENS, parece mejorar la respuesta al estreñimiento. La TENS debe considerarse una mejor opción que los anticolinérgicos en el manejo inicial de niños con VH pues carece de efectos colaterales. En la enuresis asociada a VH, la respuesta es baja con TENS. Protocolos con mayor número de casos son necesarios para confirmar los resultados aquí mostrados.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ramsay S, Bolduc S. Overactive bladder in children. CanUrol Assoc J. 2017 Jan-Feb; 11(1-2Suppl1): S74-S79.

  2. Franco I. Overactive bladder in children. Nat Rev Urol. 2016Sep;13(9):520-32.

  3. Giramonti, KM, Kogan, BA & Halpern, LF. The effects ofanticholinergic drugs on attention span and short-termmemory skills in children. Neurourol Urodyn. 2008; 27(4):315-318.

  4. Chapple CR, Cardozo L, Nitti VW, Siddiqui E, Michel MC.Mirabegron in overactive bladder: a review of efficacy,safety, and tolerability. Neurourol Urodyn. 2014; 33:17–30.

  5. De Gennaro M, Capitanucci ML, Mosiello G, ZaccaraA. Current state of nerve stimulation technique forlower urinary tract dysfunction in children. J Urol. 2011May;185(5):1571-7.

  6. Hoebeke P, Van Laecke E, Everaert K, Renson C, De PaepeH, Raes A, Vande Walle J. Transcutaneous neuromodulationfor the urge syndrome in children: a pilot study. J Urol 2001Dec;166(6):2416-9.

  7. Bower WF, Moore KH, Adams RD. A pilot study of thehome application of transcutaneous neuromodulation inchildren with urgency or urge incontinence. J Urol. 2001Dec;166(6):2420-2.

  8. Paul F Austin, Stuart B Bauer, Wendy Bower, Janet Chase,Israel Franco, Piet Hoebeke, et al. The Standardization ofTerminology of Lower Urinary Tract Function in Childrenand Adolescents: Update Report From the StandardizationCommittee of the International Children’s ContinenceSociety. Neurourology and Urodynamics 2016; 35:471-481.

  9. Lindström S, Fall M, Carlsson CA, Erlandson BE. Theneurophysiological basis of bladder inhibition in responseto intravaginal electrical stimulation. J Urol. 1983Feb;129(2):405-10.

  10. Fall M, Lindström S. Electrical stimulation. A physiologicapproach to the treatment of urinary incontinence. 1991May;18(2):393-407. Urol Clin North Am.

  11. Blok BF, Holstege G. The central control of micturition andcontinence: implications for urology. BJU Int. 1999 Mar;83. Suppl 2:1-6.

  12. Barroso U Jr, Lordêlo P. Electrical nerve stimulation foroveractive bladder in children. Nat Rev Urol. 2011. Jun7; 8(7):402-7.

  13. Jesus Lisieux Eyer de, Nery Kathia. O uso da neuromodulaçãono tratamento das disfunções de eliminações. Rev. Col.Bras. Cir. [Internet]. 2007 Dec; 34(6): 392-397.

  14. Liao KK, Chen JT, Lai KL, Liu CY, Lin CY, Lin YY, Yu BK, WuZA. Effect of sacral-root stimulation on the motor cortexin patients with idiopathic overactive bladder syndrome.Neurophysiol Clin. 2008 Feb; 38(1): 39-43.

  15. De Groat, W. C., & Kawatani, M. Neural control of theurinary bladder: Possible relationship between peptidergicinhibitory mechanisms and detrusor instability. Neurourologyand Urodynamics, 1985. 4(4), 285–300.

  16. Griffiths D, Derbyshire S, Stenger A, Resnick N. Braincontrol of normal and overactive bladder. J Urol. 2005Nov;174(5):1862-7.

  17. Griffiths D, Tadic SD. Bladder control, urgency, and urgeincontinence: evidence from functional brain imaging.Neurourol Urodyn. 2008; 27(6): 466-74.

  18. Fowler CJ, Griffiths DJ. A decade of functional brain imagingapplied to bladder control. Neurourol Urodyn. 2010;29(1): 49-55.

  19. Kutscher ML: Kids in the Syndrome Mix of ADHD, LD, Asperger’s,Tourette’s, Bipolar, and More! The one Stop Guidefor Parents, Teachers, and. Other Professionals. London:Jessica Kingsley Publishers 2005.

  20. Fitzgerald MP, Thom DH, Wassel-Fyr C, Subak L, BrubakerL, Van Den Eeden SK, Brown JS. Reproductive Risks forIncontinence Study at Kaiser Research Group. Childhoodurinary symptoms predict adult overactive bladder symptoms.J Urol. 2006 Mar; 175(3 Pt 1): 989-93.

  21. Minassian VA, Lovatsis D, Pascali D, Alarab M, Drutz HP.Effect of childhood dysfunctional voiding on urinary incontinencein adult women. Obstet Gynecol. 2006. Jun;107(6): 1247-51.

  22. Malm-Buatsi E, Nepple KG, Boyt MA, Austin JC, Cooper CS.Efficacy of transcutaneous electrical nerve stimulation inchildren with overactive bladder refractory to pharmacotherapy.Urology. 2007 Nov; 70(5): 980-3.

  23. Sillén U, Arwidsson C, Doroszkiewicz M, Antonsson H,Jansson I, Stålklint M, Abrahamsson K, Sjöström S. Effectsof transcutaneous neuromodulation (TENS) on overactivebladder symptoms in children: a randomized controlledtrial. J Pediatr Urol. 2014 Dec; 10(6): 1100-5.

  24. Lordêlo P, Teles A, Veiga ML, Correia LC, Barroso U Jr.Transcutaneous electrical nerve stimulation in childrenwith overactive bladder: a randomized clini cal trial. J Urol.2010 Aug; 184(2): 683-9.

  25. Lordêlo P, Soares PV, Maciel I, Macedo A Jr, Barroso U Jr.Prospective study of transcutaneous parasacral electricalstimulation for overactive bladder in children: long-termresults. J Urol. 2009 Dec; 182(6): 2900-4.

  26. Lordêlo P, Benevides I, Kerner EG, Teles A, Lordêlo M, BarrosoU Jr. Treatment of non-monosymptomatic nocturnalenuresis by transcutaneous parasacral electrical nervestimulation. J Pediatr Urol. 2010 Oct; 6(5): 486-9.

  27. de Oliveira LF, de Oliveira DM, da Silva de Paula LI, deFigueiredo AA, de Bessa J Jr, de Sá CA, Bastos Netto JM.Transcutaneous parasacral electrical neural stimulationin children with primary monosymptomatic enuresis: aprospective randomized clinical trial. J Urol. 2013 Oct;190(4): 1359-63.

  28. Hoffmann A, Sampaio C, Nascimento AA, Veiga ML, BarrosoU. Predictors of outcome in children and adolescents withoveractive bladder treated with parasacral transcutaneouselectrical nerve stimulation. J Pediatr Urol. 2018 Feb;14(1): 54.e1-54.e6.

  29. Finazzi Agrò E, Campagna A, Sciobica F, Petta F, GermaniS, Zuccalà A, Miano R. Posterior tibial nerve stimulation:is the once-a-week protocol the best option? 2005.Jun;57(2):119-23. Minerva Urol Nefrol.

  30. de Paula LIDS, de Oliveira LF, Cruz BP, de Oliveira DM, MirandaLM, de Moraes Ribeiro M, Duque RO, de FigueiredoAA, de Bessa J Jr, Netto JMB. Parasacral transcutaneouselectrical neural stimulation (PTENS) once a week for thetreatment of overactive bladder in children: A randomizedcontrolled trial. J Pediatr Urol. 2017. Jun;13(3):263.e1-263.e6.

  31. Meek PD, Evang SD, Tadrous M, Roux-Lirange D, Triller DMand Gumustop B: Overactive bladder drugs and constipation:a meta-analysis of randomized, placebo-controlledtrials. Dig Dis Sci 2011, 56(1): 7-18.

  32. Chapple CR, Mironska E, Wagg A, Milsom I, Diaz DC, KoelblH, Pushkar D, Tubaro A, De Ridder D, Chartier-Kastler E andPhillips LD: Multicriteria decision analysis applied to theclinical use of pharmacotherapy for overactive bladdersymptom complex. Eur Urol Focus 2020, 6(3): 522-530.

  33. Hirota CL and McKay DM: Cholinergic regulation of epitelialion transport in the mammalian intestine. Br J Pharmacol2006;149(5): 463-479.

  34. Veiga ML, Lordêlo P, Farias T, Barroso C, Bonfim J, BarrosoU Jr. Constipation in children with isolated overactive bladders.J Pediatr Urol. 2013 Dec; 9(6 Pt A): 945-9.

  35. Veiga ML, Lordêlo P, Farias T, Barroso U Jr. Evaluation of constipationafter parasacral transcutaneous electrical nervestimulation in children with lower urinary tract dysfunction--a pilot study. J Pediatr Urol. 2013 Oct; 9(5): 622-6.

  36. Sampaio C, Sousa AS, Fraga LG, Veiga ML, Bastos Netto JM,Barroso U Jr. Constipation and lower urinary tract dysfunctionin children and adolescents: a population-based study.Front Pediatr. 2016. 4:101.

  37. Meek PD, Evang SD, Tadrous M, Roux-Lirange D, Triller DM,Gumustop B. Overactive bladder drugs and constipation:a meta-analysis of randomized, placebo-controlled trials.Dig Dis Sci. 2011 Jan; 56(1): 7-18.

  38. Tugtepe H, Thomas DT, Ergun R, Kalyoncu A, Kaynak A,Kastarli C, Dagli TE. The effectiveness of transcutaneouselectrical neural stimulation therapy in patients with urinaryincontinence resistant to initial medical treatmentor biofeedback. J Pediatr Urol. 2015. Jun; 11(3): 137.e1-5.

  39. Dos Reis JN, Mello MF, Cabral BH, Mello LF, Saiovici S, RochaFET. EMG biofeedback or parasacral transcutaneous electricalnerve stimulation in children with lower urinary tractdysfunction: A prospective and randomized trial. NeurourolUrodyn. 2019. Aug; 38(6):1588-1594.

  40. Veiga ML, Costa EV, Portella I, Nacif A, Martinelli Braga AA,Barroso U Jr. Parasacral transcutaneous electrical nervestimulation for overactive bladder in constipated children:The role of constipation. J Pediatr Urol. 2016. Dec;12(6):396.e1-396.e6.

  41. Kay GG, Granville LJ. Antimuscarinic agents: implicationsand concerns in the management of overactive bladder inthe elderly. Clin Ther. 2005; 27 (1): 127-138.

  42. Callegari E, Malhotra B, Bungay PJ, et al. A comprehensivenonclinical evaluation of the CNS penetration potentialof antimuscarinic agents for the treatment of overactivebladder. Br J Clin Pharmacol. 2011; 72 (2): 235-246.

  43. Chandellor MB, Staskin DR, Kay GG, Sandage BW, OefeleinMG, Tsao JW. Blood-brain barrier permeation and effluxexclusion of anticholinergics used in the treatment ofoveractive bladder. Drugs Aging. 2012; 29 (4):259-273.

  44. Akino H, Namiki M, Suzuki K, Fuse H, Kitagawa Y, MiyazawaK, Fujiuchi Y and Yokoyama O: Factors influencing patientsatisfaction with antimuscarinic treatment of overactivebladder syndrome: results of a real-life clinical study. Int JUrol 21(4): 389-394, 2014.




2020     |     www.medigraphic.com